Leadership

Deeply Experienced.
Immuno-Oncology Focused.

The grand vision behind OncoBay’s CRO solutions has become an exciting reality. Our leadership is a widely respected team of industry professionals with more than 100 years of experience to their credit. They are keenly focused on helping biotech firms conduct effective and efficient clinical trials to advance immuno-oncology research.

Krystyna Kowalczyk

Chief Executive Officer

Krystyna Kowalczyk

Krystyna has spent over 25 years in leadership roles in small and large CROs with extensive COO-level experience building operational teams and leading global trial execution. Throughout her career, she has focused on creating an environment of opportunity and hope for patients with cancer and other rare diseases. Now leading OncoBay Clinical, Krystyna continues her mission to change the paradigm of clinical trial operations and patient access through technology and innovation.

Charles Lambert

Chief Financial Officer

Charles Lambert

Charles has spent over 30 years serving in CFO roles, in the United States and internationally, for a wide range of industries. Prior to OncoBay, he served for nine years as the CFO for a full-service, global CRO. Charles has had extensive M & A experience, both buying and selling, and in subsequent integration. In addition, he has a proven track record for building finance teams in both large and small companies, improving cashflow and driving breaking growth.

Dannelle Palmer

Vice President of Clinical Operations

Dannelle Palmer

Dannelle has over 20 years of global clinical development experience in pharmaceuticals, biotechnologies, and global CRO organizations leading clinical research teams with an emphasis on enhancing the performance and efficiency of oncology clinical research. Dannelle’s expertise and experience ranges from clinical development planning and regulatory consulting to leading studies from first in human through FDA and EMA approval. For the past 13 years, she has held executive level positions focused on portfolio leadership, strategic leadership, and customer relationship development.

Deborah Turunjian

Vice President of Business Operations

Deborah Turunjian

Deborah has spent over 30 years in leadership roles with a strong track record of building high-functioning teams and successfully executing global clinical programs within both CROs and Bio-techs. She has held vice presidential positions in oncology project management, business optimization, strategic partnerships development and clinical outsourcing. Earlier in her career, Deborah also held leadership positions in the areas of marketing, corporate communications and investor relations, and served as a member of several integration teams following corporate acquisitions and mergers in both the life science and high-tech industries.

Richard Busby

Vice President Marketing and Business Development

Richard Busby

As a clinical research veteran, Richard Busby has over 25 years of experience in both Clinical Operations as well as Business Development. With a proven track record of forging strategic relationships with emerging and established Oncology Biotech and Pharma sponsors, Richard draws from his operational foundation, bringing a practical experience and perspective to discussions with prospective clients. He has worked to assemble and offer a variety of creative models to meet his client’s needs – from functional service models to customized preferred providers of targeted services to full turn-key CRO solutions. Now leading OncoBay Clinical Business Development, Richard will focus on working collaboratively and creatively across OncoBay and Sponsor teams to develop and deliver custom curated solutions with an eye on customer satisfaction above all else.

Pam Sneed

Senior Director of Clinical Operations

Pam Sneed

Pam has more than 19 years of experience in the CRO industry, leading international clinical project management teams. Over the last decade, she has been instrumental in growth of new business, development of client partnerships and improvement of processes. Pam has start-to-finish global program level and clinical trial management experience across all study phases. She has consistently managed high quality clinical trials throughout her career and takes pride in mentoring and fostering career growth within project teams.

Lisa Gritton

Director of Business Development

Lisa Gritton

Lisa brings nearly 20 years of proven business development and account management. She has spent most of her career within the pharmaceutical industry on both the commercial and clinical development side. Prior to joining OncoBay, Lisa held account director positions for global healthcare enterprises specializing in patient recruitment and investigator sites. While her experience spans many different therapeutic areas including oncology, Lisa’s passion is for customer relationship development to ultimately impact the lives of many patients in need of new life-saving therapies.

The Latest News & Events

SEE ALL NEWS & EVENTS

Take Advantage of OncoBay’s Innovative Approach

CONTACT ONCOBAY CLINICAL